Brainreader is a life science company in the field of brain volumetrics. Brainreader’s flagship software, Neuroreader®, is a support tool that provides volume statistical assessment of the brain to assist clinicians in discovering neurodegenerative diseases. Early diagnoses can result in treatment plans that improve quality of life and help patients and families cope with these diseases.
Neuroreader® is FDA cleared, CE marked and uses high resolution 3D T1 images as part of a routine MRI of the brain.
The Neuroreader® software automates quantification for fast and accurate assessment of brain volumetric data and eliminates the need for manual segmentation.
It is ideal for both clinical and research use.
Established in 2011.